tabrecta - capmatinib tablet, film coated
(Capmatinib)Novartis Pharmaceuticals Corporation
Usage: Tabrecta treats adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a MET exon 14 skipping mutation detected by an FDA-approved test.